A healthcare technology company affected by the pandemic doesn't add up. The last two years could have been their best and only opportunity to make an impact. Palantir was awarded a £480 million contract by the NHS for a federated data platform. One should ask why Alcidion has not won any substantial contracts there. Is it due to poor UK leadership or a basic product offering? They havent won any substantial contracts in Australia as well since defence?
ALC Price at posting:
10.5¢ Sentiment: Hold Disclosure: Held
